Skip to contentU
Ultralife Corp
U
ULBIUltralife Corp Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$43.85M$43.85Mderived−1.6% vs Q4 2023 Net Income$194.00K$194.00Kderived−93.2% vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ultralife Corp · CIK 875657 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$10,599,000−7.0% Operating Incomederived$1,474,000−59.6% Operating Cash Flowderived$3,046,000+25.2% Free Cash Flowderived$2,440,000+71.0% Margins · derivedGross margin24.2%−1.4 pt vs Q4 2023
Operating margin3.4%−4.8 pt vs Q4 2023
Net margin0.4%−6.0 pt vs Q4 2023
ended Dec 31, 2024 · filed Apr 1, 2025 · 91 d after period end